Results 221 to 230 of about 42,414 (275)

Comparison of Inactivated Poliovirus Vaccine and Oral Poliovirus Vaccine Programs in Israel

Clinical Infectious Diseases, 1984
In spite of high vaccination coverage, paralytic poliomyelitis still occurs in Israel, either in sporadic form in the urban area or in small outbreaks in the rural, non-Jewish segment. At high risk are mainly very young infants, not yet protected by poliovirus vaccine and children who have failed to seroconvert after a full course of oral poliovirus ...
Goldblum N, E. Ben-Porath, Leitner L, H. Kanaaneh, Swartz Ta   +4 more
openaire   +2 more sources

Oral poliovirus vaccination and pregnancy complications

Acta Obstetricia et Gynecologica Scandinavica, 1995
Background. To determine whether the effect of live attenuated oral polio virus vaccine given to pregnant women increases pregnancy complications.Methods. A study of women who had been vaccinated against poliovirus during a national vaccination campaign and who had delivered by cesarean section in three obstetrical hospitals in southern Finland.
Tina Harjulehto-Mervaala, Vilho Hiilesmaa, Tapani Hovi, Timo Aro, Harri Saxen   +4 more
openaire   +3 more sources

Sequential Use of Inactivated Poliovirus Vaccine followed by Oral Poliovirus Vaccine in Oman

Journal of Infectious Diseases, 1997
Seroprevalence and geometric mean titers (GMTs) were compared at 6 and 10 months after vaccination with monovalent type 1 oral poliovirus vaccine (OPV) at 6 months and trivalent OPV at 7 and 9 months. Group 1 had received 4 doses of OPV, group 2 OPV at birth and 3 doses of OPV and inactivated poliovirus vaccine (IPV), and group 3 placebo at birth and 3
Pradeep Malankar, Susan E. Robertson, Ali Jaffer M. Suleiman, Roland W. Sutter, Mahmud A. Medany, Mark A. Pallansch, Robert W. Linkins, Firdosi R. Mehta, Mussalam S. El-Bualy, Mohammed Amir M. Arif   +9 more
openaire   +3 more sources

Modeling the Dynamics of Oral Poliovirus Vaccine Cessation

The Journal of Infectious Diseases, 2014
Abstract Background.  Oral poliovirus vaccine (OPV) results in an ongoing burden of poliomyelitis due to vaccine-associated paralytic poliomyelitis and circulating vaccine-derived polioviruses (cVDPVs). This motivates globally coordinated OPV cessation after wild poliovirus eradication. Methods.
Thompson, Kimberly M., Tebbens, Radboud J.Duintjer   +1 more
openaire   +4 more sources

Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine

European Journal of Epidemiology, 1988
A vaccination trial, performed on 86 3-month-old infants, has shown that the ability of the RIT 4237 live attenuated rotavirus strain to induce seroconversion is dramatically reduced when administered with live poliovirus vaccine. In a subsequent trial performed on 93 infants the attempt to overcome the poliovirus interference by administering two ...
GIAMMANCO G, DE GRANDI V, LUPO, Lorenzo, MISTRETTA, Antonio, PIGNATO S, TEUWEEN D, BOGAERTS H, ANDRE’F E.   +7 more
openaire   +4 more sources

Live Oral Poliovirus Vaccines and Simian Cytomegalovirus

Biologicals, 2002
Live oral poliovirus vaccines (OPV) are often produced in primary Cercopithecus monkey kidney (CMK) cells. The kidneys of these monkeys are often latently infected with simian cytomegalovirus (SCMV), and CMK cultures are frequently contaminated with SCMV.
Ana Maria Sierra-Honigmann, Philip R. Krause   +1 more
openaire   +2 more sources

Efficacy and safety of oral poliovirus vaccine and inactivated poliovirus vaccine

Pediatric Infectious Disease, 1991
Inactivated poliovirus vaccine (IPV) is the vaccine of choice for protection against paralytic poliomyelitis provided that it is used within the context of a program to increase and sustain the level of uptake to as close to 100% as possible. This means targeting the disadvantaged in society as well as those who have their own pediatrician. The reasons
openaire   +2 more sources

Immunization with Oral Poliovirus Vaccine in China

Clinical Infectious Diseases, 1984
China began to produce oral, live poliovirus vaccine ( OPV ) in 1960. During 1960-1964, OPV was introduced in major cities only and subsequently was used throughout the country. Since that time the incidence of poliomyelitis has dropped dramatically, and the percentage of the healthy population with antibody has clearly risen.
openaire   +4 more sources

Simian cytomegalovirus and contamination of oral poliovirus vaccines

Biologicals, 2003
In the 1950s the use of primary rhesus macaque kidney cultures to propagate poliovirus for vaccine production led to the contamination of vaccines with simian virus 40 (SV40). African green monkey kidney (AGMK) cultures free of SV40 were used as an alternative cell substrate for vaccine manufacture.
Nita Shah, Neil Berry, Philip D. Minor, Adrian Jenkins, Sally A. Baylis   +4 more
openaire   +3 more sources

Live Attenuated Oral Poliovirus Vaccine

Clinical Infectious Diseases, 1984
During 1952-1954, some of the first papers were published on the attenuation of wild poliovirus for vaccine purposes. These efforts soon came to fruition , and large-scale field trials were held in many countries under a variety of conditions. Routine use of live oral poliovirus vaccines ( OPV ) was begun in many countries during the spring of 1960 ...
openaire   +3 more sources